Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

Anti-HBs is a neutralizing antibody and its presence suggests the recovery from hepatitis B and confers a long-term ... These patients usually harbor precore/core promoter mutations in the HBV ...

Here we investigated the hepatitis B core protein (HBc) that forms the viral capsids and plays a vital role in ... After treatment, the live cells were fixed and labelled with HBc Antibody and a ...

ALT: Alanine aminotransferase; Anti-HBc: Hepatitis B core antibody; Anti-HBe: Hepatitis B e antibody; Anti-HBs: Hepatitis B surface antibody; HBeAg: Hepatitis B e antigen; HBsAg: Hepatitis B ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

Hepatitis B (sometimes referred to as hep B) is a liver infection caused by the hepatitis B virus (HBV). It typically causes symptoms like stomach pain, dark urine, fatigue, fever, jaundice (yellowing ...

Hepatitis B is inflammation of the liver in hominoidea, including humans, caused by the hepatitis B virus. The virus is transmitted by parenteral exposure, such as by exposure to infectious blood ...

In this paper, the authors present an interesting strategy to interfere with the HBV life cycle: the preparation of geranyl and peptides' dimers that could impede the correct assembly of hepatitis B ...

The hepatitis B vaccine protects against liver infection caused by the hepatitis B virus (HBV). This virus is highly contagious and can spread through exposure to blood, semen, and other bodily ...

Concerns over privacy or discrimination may have further prevented individuals with suspected chronic HBV infection to present for testing. Further, other HBV markers like hepatitis B core antibody ...

Aim: The study aimed to explore the coexisting patterns and assess the significance of serum hepatitis B virus (HBV) RNA and traditional virological biomarkers in patients with antiviral ...